What's Happening

Stay up to date on conferences, social posts, and what’s new with Healthesystems

Events

Let’s connect at one of our upcoming conferences or speaking engagements
March 21 - Mar 22, 2024

California DWC Annual Conference

Healthesystems is attending the California Division of Workers’ Compensation Annual Educational Conference for those who participate in the CA workers’ comp system.

Los Angeles, CA
March 27 - Mar 29, 2024

Ohio Safety Congress & Expo

Healthesystems is attending the Ohio Bureau of Workers’ Compensation Safety Congress & Expo, the nation’s largest free occupational safety conference focusing on helping employers improve safety and health within their business.

Columbus, OH
View all Events

MedMonitor

An up-to-date timeline of FDA approvals that could impact workers' comp
View All MedMonitor Information

Tofidence (tocilizumab-bavi) injection 

Approval Date: Sep 2023

Note: New Product

Indicated for the treatment of rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs)

hello world!

Xeljanz (tofacitinib) oral solution

Approval Date: Sep 2023

Note: First-Time Generic

Indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis

hello world!

Exxua (gepirone) extended-release tablets

Approval Date: Sep 2023

Note: New Product

Indicated for the treatment of major depressive disorder (MDD), a first-in-class drug that selectively targets the serotonin 1A receptor

hello world!

Lexette (halobetasol propionate) topical foam

Approval Date: Aug 2023

Note: First-Time Generic

Indicated for the topical treatment of plaque psoriasis

hello world!

Onglyza (saxagliptin) tablets

Approval Date: Jul 2023

Note: First-Time Generic

Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

hello world!

Kombiglyze® XR (saxagliptin and metformin hydrochloride) extended-release tablets

Approval Date: Jul 2023

Note: First-Time Generic

Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin and metformin is appropriate

hello world!

RiVive (naloxone hydrochloride) nasal spray

Approval Date: Jul 2023

Note: New Product

Indicated for the emergency treatment of known or suspected opioid overdose, this drug is the second over-the-counter nonprescription opioid overdose drug approved by the FDA

hello world!

Spiriva® HandiHaler (tiotropium bromide) inhalation powder

Approval Date: Jun 2023

Note: First-Time Generic

For the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

hello world!

Katerzia® (amlodipine benzoate) oral suspension

Approval Date: Jun 2023

Note: First-Time Generic

For the treatment of hypertension and coronary artery disease

hello world!

Fleqsuvy (baclofen) oral suspension

Approval Date: Jun 2023

Note: First-Time Generic

Indicated for the treatment of spasticity resulting from multiple sclerosis, as well as in patients with spinal cord injuries or diseases.

hello world!

Social Hub

Check out our latest posts and activity
View All Social Media
    lockenvelopephone-handsetmagnifiermenucross-circle